Korean J Gastroenterol.  2007 Dec;50(6):379-383.

A Case of Acute Pancreatitis Caused by 5-aminosalicylic Acid Suppositories in a Patient with Ulcerative Colitis

Affiliations
  • 1Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea. jbi@med.yu.ac.kr

Abstract

Oral 5-aminosalicylic acid (5-ASA) has been known as a first-choice drug for ulcerative colitis. However, hypersensitivity reactions, including pancreatitis, hepatitis, and skin rash, have been reported with 5-ASA. Topical formulations of 5-ASA like suppositories have been rarely reported to induce adverse reactions because of their limited absorption rate. We recently experienced a case of acute pancreatitis caused by 5-ASA suppositories in a patient with ulcerative colitis. A 26-year-old male was admitted with abdominal pain and diagnosed as ulcerative colitis. Acute pancreatitis occurred soon after 24 hours of treatment with oral mesalazine. Drug-induced pancreatitis was suspected and administration of mesalazine was discontinued. Then 5-ASA suppositories were started instead of oral mesalazine. Twenty-four hours after taking 5-ASA suppositories, he experienced severe abdominal pain, fever, and elevation of amylase levels. The suppositories were immediately stopped and symptoms resolved over next 48 hours. Herein, we suggest that, in patients treated with 5-ASA suppositories who complain of severe abdominal pain, drug-induced pancreatitis should be suspected.

Keyword

Acute pancreatitis; 5-aminosalicylic acid; Ulcerative colitis

MeSH Terms

Acute Disease
Adult
Anti-Inflammatory Agents, Non-Steroidal/administration & dosage/*adverse
Colitis, Ulcerative/diagnosis/*drug therapy
Humans
Male
Mesalamine/administration & dosage/*adverse effects/therapeutic use
Pancreatitis/*chemically induced/*diagnosis
Suppositories
Tomography, X-Ray Computed
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr